Dynamics of HER3 and its correlated gene expression profile in EGFR-mutated NSCLC tumor treated with EGFR-TKI toward enhancing effectiveness of patritumab deruxtecan (HER3-DXd; U3-1402).-MedSci.cn

Dynamics of HER3 and its correlated gene expression profile in EGFR-mutated NSCLC tumor treated with EGFR-TKI toward enhancing effectiveness of patritumab deruxtecan (HER3-DXd; U3-1402).

Yonesaka, K; Tanizaki, J; Maenishi, O; Haratani, K; Kawakami, H; Tanaka, K; Hayashi, H; Sakai, K; Chiba, Y; Goto, H; Otsuka, E; Okida, H; Kobayashi, M; Yoshimoto, R; Funabashi, M; Hashimoto, Y; Hirotani, K; Kagari, T; Nishio, K; Nakagawa, K

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

科室
- - 订阅+
  - 更多科室
工具
服务